Did Bacillus megaterium pick up plasmid virulence genes?

Includes bibliographical references.Plasmids are known to carry genes that allow bacteria to survive in different environments. Virulence genes that cause bacteria to be pathogenic are also found on plasmids. Bacillus megaterium is a non-pathogenic, spore-forming bacteria that is found in soil, but recently a strain of B. megaterium was reported to cause a mild case of diarrhea in an infant. This appears to be the first case of infection caused by B. megaterium (CHI). Bacillus cereus is a related species and a known gastroenteric pathogen. Research has shown that the pathogenicity in some strains of B. cereus is caused by either an operon containing four genes, hblA/B/C/D, or by a single gene, bceT. The pathogenic strain of B. megaterium, (CHI), was tested by PCR and hybridization, to see if it picked up either of these two factors that cause pathogenicity in B. cereus by plasmid exchange. PCR products were obtained in CHI for the genes hblA and bceT using specific primers suggesting that such genes are present in the B. megaterium (CHI) strain. However, a hybridization experiment using bceT product as a probe for CHI failed to show a signal.B.S. (Bachelor of Science

Evaluation of Philippine-sourced clay particles as coating agents of cacao pods and carrier of entomopathogen against cacao pest, Helopeltis bakeri Poppius

Evaluation of the efficacy of clay particles as a coating agent of cacao pods and carrier of entomopathogen, Metarhizium anisopliae Sorokin, was conducted for the control of cacao mirid bug (CMB), Helopeltis bakeri Poppius. Choice and no-choice tests were performed to evaluate Philippine-sourced clay particles as a coating agent of cacao pods to deter CMB feeding, in comparison with the commercially available particle film (US kaolin Surround®). To determine the most efficient local clay particles in protecting the pods from CMB feeding, six (6) treatments were evaluated namely, Philippine-sourced kaolin (PH kaolin), zeolite (PH zeolite), bentonite (PH bentonite), US kaolin, water (negative control), and a commercial synthetic insecticide thiamethoxam (Actara®) (positive control). All treatments were subjected to choice and no-choice tests. Among the Philippine clay particles tested in both tests, PH zeolite showed significant coating and deterred CMB from feeding. Since the US Kaolin and zeolite showed significant feeding deterrent effects on CMB, these treatments were tested as carriers of entomopathogenic fungi, M. anisopliae, including water (negative control) and thiamethoxam. Results showed that zeolite is a good carrier of the spores of M. anisopliae as its effects to deter CMB feeding started 24 hours after exposure. This was confirmed by positive M. anisopliae extraction from dead CMB through potato dextrose agar (PDA) plating

Insulinoma Presenting with Psychiatric Manifestations: A Case Report

Insulinomas, the most common of pancreatic endocrine tumors, usually present with neuroglycopenic and adrenergic features. Chronic or long standing recurrent hypogycaemia can produce intellectual deterioration and neuropsychiatric manifestations. Diagnosis of insulinoma relies on clinical features along with laboratory tests and imaging investigations to aid in localization. A 32-year-old male who presented with prominent neuropsychiatric manifestations and received anti-epileptics as a case of epilepsy and was ultimately diagnosed as insulinoma is reported here. The patient experienced fasting hypoglycemia with neuropsychiatric manifestations; computerized tomography (CT scan) and magnetic resonance imaging (MRI) revealed a diffusely enhanced mass in the head area of pancreas which was histopathologically found to be an insulinoma after hand assisted laparoscopic enucleation. Surgical excision is the treatment of choice and is curative in most cases. Key words: Insulinoma; Psychiatric Manifestation.DOI: 10.3329/bsmmuj.v2i1.3710 BSMMU J 2009; 2(1): 39-4

Investigation of magnetization reversal processes in Sm(Co, Fe, Cu, Zr)7.5 magnets

The processes of magnetization reversal in isotropic and anisotropic commercial permanent magnets Sm(Co, Fe, Cu, Zr)7.5 were investigated. Features of magnetization reversal process in both textured and isotropic magnets were analyzed with δM(H) plots, magnetic susceptibility and initial magnetization curves. The magnetization reversal of Sm(Co, Fe, Cu, Zr)7.5 magnets is more complicated than that described in the coercivity model based on the domain walls pinning. © Published under licence by IOP Publishing Ltd.The work was supported by Act 211 Government of the Russian Federation, contract № 02.A03.21.0006

Clinical pattern of tolvaptan-associated liver injury in trial participants with autosomal dominant polycystic kidney disease (ADPKD): An analysis of pivotal clinical trials

RATIONALE & OBJECTIVE: Tolvaptan is associated with risk of drug-induced liver injury when used to treat autosomal dominant polycystic kidney disease (ADPKD). After this risk was described based on the clinical trials TEMPO 3:4 and TEMPO 4:4, additional data from the REPRISE trial and a long-term extension of TEMPO 4:4, REPRISE, and other tolvaptan trials in ADPKD have become available. To further characterize the hepatic safety profile of tolvaptan, an analysis of the expanded dataset was conducted. STUDY DESIGN: Analysis of safety data from prospective clinical trials of tolvaptan. SETTING & PARTICIPANTS: Multicenter clinical trials including more than 2,900 tolvaptan-treated participants, more than 2,300 with at least 18 months of drug exposure. INTERVENTION: Tolvaptan administered twice daily in split-dose regimens. OUTCOMES: Frequency of liver enzyme level increases detected by regular laboratory monitoring. RESULTS: In the placebo-controlled REPRISE trial, more tolvaptan- than placebo-treated participants (38 of 681 [5.6%] vs 8 of 685 [1.2%]) experienced alanine aminotransferase level increases to \u3e3× the upper limit of normal (ULN), similar to TEMPO 3:4 (40 of 957 [4.4%] vs 5 of 484 [1.0%]). No participant in REPRISE or the long-term extension experienced concurrent alanine aminotransferase level increases to \u3e3× ULN and total bilirubin increases to \u3e2× ULN ( Hy\u27s Law laboratory criteria). Based on the expanded dataset, liver enzyme increases most often occurred within 18 months after tolvaptan initiation and were less frequent thereafter. Increased levels returned to normal or near normal after treatment interruption or discontinuation. Thirty-eight patients were rechallenged with tolvaptan after the initial drug-induced liver injury episode, with return of liver enzyme level increases in 30; 1 additional participant showed a clinical adaptation after the initial episode, with resolution of the enzyme level increases despite continuation of tolvaptan. LIMITATIONS: Retrospective analysis. CONCLUSIONS: The absence of Hy\u27s Law cases in REPRISE and the long-term extension trial support monthly liver enzyme monitoring during the first 18 months of tolvaptan exposure and every 3 months thereafter to detect and manage enzyme level increases, as is recommended on the drug label. FUNDING: Otsuka Pharmaceutical Development & Commercialization, Inc. TRIAL REGISTRATION: Trials included in the dataset were registered at ClinicalTrials.gov with study numbers NCT00428948 (TEMPO 3:4), NCT01214421 (TEMPO 4:4), NCT02160145 (REPRISE), and NCT02251275 (long-term extension)

The Amino-Terminus of Nitric Oxide Sensitive Guanylyl Cyclase α1 Does Not Affect Dimerization but Influences Subcellular Localization

BACKGROUND: Nitric oxide sensitive guanylyl cyclase (NOsGC) is a heterodimeric enzyme formed by an α- and a β₁-subunit. A splice variant (C-α₁) of the α₁-subunit, lacking at least the first 236 amino acids has been described by Sharina et al. 2008 and has been shown to be expressed in differentiating human embryonic cells. Wagner et al. 2005 have shown that the amino acids 61-128 of the α₁-subunit are mandatory for quantitative heterodimerization implying that the C-α₁-splice variant should lose its capacity to dimerize quantitatively. METHODOLOGY/PRINCIPAL FINDINGS: In the current study we demonstrate preserved quantitative dimerization of the C-α₁-splice by co-purification with the β₁-subunit. In addition we used fluorescence resonance energy transfer (FRET) based on fluorescence lifetime imaging (FLIM) using fusion proteins of the β₁-subunit and the α₁-subunit or the C-α₁ variant with ECFP or EYFP. Analysis of the respective combinations in HEK-293 cells showed that the fluorescence lifetime was significantly shorter (≈0.3 ns) for α₁/β₁ and C-α₁/β₁ than the negative control. In addition we show that lack of the amino-terminus in the α₁ splice variant directs it to a more oxidized subcellular compartment. CONCLUSIONS/SIGNIFICANCE: We conclude that the amino-terminus of the α₁-subunit is dispensable for dimerization in-vivo and ex-vivo, but influences the subcellular trafficking

REMAGNETIZATION PROCESSES IN SINTERED Sm-Co И Nd-Fe-B PERMANENT MAGNETS

The processes of remagnetization in permanent magnets of the Sm2Co17 and Nd2Fe14B systems were studied. The mechanism for the formation of coercivity is established via su-perposition coherent rotation or pinning in accordance of the Kondorski and Stoner-Wohlfarth models.Проект выполнен при финансовой поддержке Российского фонда фундаментальных исследований, грант № 20-32-90211\20

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead